Genotropin is a synthetic human growth hormone. It is a replacement therapy for children with growth hormone deficiency. The powder is white in colour. The solvent is a colourless clear solution.
Somatropin enhances and accelerates linear skeletal growth. Genotropin is prescribed with caution in diabetics. It is dispensed with a doctor's prescription. Normally, during somatropin therapy, peripheral blood thyroid hormone concentrations remain within normal limits. However, during therapy, the conversion of the hormone T4 into T3 is activated, resulting in a decrease in T4 concentrations and an increase in serum T3 concentrations. This effect of somatropin may be of clinical importance in patients with a latent subclinical form of central hypothyroidism.
Hypersensitivity (including to solvent components);
Presence of symptoms of tumour growth;
The dose is adjusted individually according to the weight or surface area of the body and the location of the Genotropin should be changed each time. Injections should be made subcutaneously and the injection sites should be changed to prevent lipoatrophy.